Skip to main content
← All trials
Cancer, MetastaticDigital healthChildren's health

What this study is

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

What's being tested

  • Clinical Trial Matching

    Intervention · OTHER

    Using a proprietary application programming interface (API) linked to existing electronic health records (EHR) platforms, individual clinical data is extracted, analyzed and matched to a parametric database of existing institutional and non-institutional CT. Machine learning algorithms allow for dynamic matching based on CT allocation and availability for optimized matching.

Study details

Sponsor
Massive Bio, Inc.
Conditions
Cancer, Metastatic · Cancer · Cancer of Pancreas · Cancer of Liver · Cancer of Stomach · Cancer Liver · Cancer of Rectum · Cancer of Kidney · Cancer of Esophagus · Cancer of Cervix · Cancer of Colon · Cancer of Larynx · Cancer, Lung · Cancer, Breast · Cancer, Advanced · Cancer Prostate · Cancer of Neck · Cancer of Skin · Neuroendocrine Tumors · Carcinoma · Mismatch Repair Deficiency · BRCA Gene Rearrangement · Non Hodgkin Lymphoma · Leukemia · Non Small Cell Lung Cancer · Cholangiocarcinoma · Glioblastoma · Central Nervous System Tumor · Melanoma · Urothelial Carcinoma · Bladder Cancer · Ovarian Cancer · Endometrial Cancer · Testicular Cancer · Breast Cancer · COVID · Myelofibrosis · Myeloproliferative Neoplasm · Myeloproliferative Disorders · Follicular Lymphoma · Mantle Cell Lymphoma · Marginal Zone Lymphoma · Myelodysplastic Syndromes
Enrolling
50,000 people
Starts
2018-01-01
Est. completion
2040-06
Record
View on ClinicalTrials.gov ↗